Added to YB: 2025-10-10
Pitch date: 2025-10-07
RNA [bullish]
Avidity Biosciences, Inc.
+54.94%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
Market Cap
$11.3B
Pitch Price
$46.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-13.14
P/E
-14.65
EV/Sales
514.55
Sector
Biotechnology
Category
growth
Show full summary:
ClearBridge SMID Cap Growth Strategy New Position: Avidity Biosciences, Inc.
RNA (new position): Biotech w/ RNA therapeutics platform; 3 advanced programs generating clinical data over next year, all potential blockbusters in high unmet medical need areas; large addressable markets; added to portfolio as innovative SMID growth play.
Read full article (1 min)